Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Optimal Duration of Neoadjuvant Letrozole for Breast Cancer Unclear
Link ID 4147
Title Optimal Duration of Neoadjuvant Letrozole for Breast Cancer Unclear
Url http://www.medscape.com/viewarticle/571586?src=rss
Description Most postmenopausal breast cancer patients undergoing neoadjuvant treatment with the nonsteroidal aromatase inhibitor letrozole experience tumor volume reduction within 4 months, according to the findings of a phase IIb/III trial, but no optimal duration of therapy has yet been established. Reuters Health Information
Category Articles > Obstetrics and Gynecology
Keywords
Date Mar 20, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Obstetrics and Gynecology
1. New Model Predicts Breast Cancer Risk in African American Women
  A new model predicts the individualized risk of invasive breast cancer in African American women, according to a report in the December 5th issue of the Journal of the National Cancer Institute. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


2. Single Gene Alters Expression of Many Genes to Promote Breast Cancer Growth
  The SATB1 gene reprograms the expression of more than 1000 other genes to facilitate breast cancer growth and metastasis, according to a new report. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


3. Late Treatment With Letrozole Reduces Breast Cancer Recurrence
  Treatment with the aromatase inhibitor letrozole improves disease-free survival, even when several years have passed since completing 5 years of tamoxifen for treatment of early breast cancer. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


4. Megestrol Acetate Reduces Hot Flashes in Women With Breast Cancer
  A 20-mg daily dose of the progestin megestrol acetate significantly reduces vasomotor symptoms in women with breast cancer, according to the results of a multicenter, phase III, double-blind, trial published in the April 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


5. Calculated Cost of Assisted Reproduction Can Help in Decision Making
  The cost of a live birth using assisted reproduction technologies (ART) exceeds $100,000 when the probability of a live birth falls below 15%, according to a new cost analysis published in the January issue of Fertility and Sterility. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS